The Biotech market is taking a hit, Replimune stock tumbles 20% after FDA raises efficacy concerns Replimune Group Inc. (NASDAQ: REPL) shares fell 20% Tuesday after the FDA released briefing documents ahead of a Cellular, Tissue, and Gene Therapies Advisory Committee...
Anxious bond market, U.S. yields ease off multi-month peaks U.S. Treasury yields edged modestly lower on Tuesday, as fixed-income desks consolidated recent gains while bracing for a high-stakes Federal Reserve policy decision that has left markets increasingly...
Merging for better solutions, Stagwell to acquire Colombia-based Adobe consultant QStrauss Stagwell (STGW) has entered into an agreement to acquire QStrauss Consulting, a Colombia-based Adobe implementation and consulting firm, according to a company press...
That’s a huge fall, Capricor Therapeutics stock Falls 26% Following FDA Briefing Capricor Therapeutics (NASDAQ:CAPR) shares fell 40% Monday after the FDA posted briefing documents ahead of the company’s July 29 advisory committee meeting.The Cellular, Tissue,...
A private matter, Luxfer to be taken private by Wynnchurch Capital Luxfer Holdings PLC (NYSE: LXFR) has agreed to be acquired by affiliates of Wynnchurch Capital, L.P. in an all-cash transaction at $17.37 per ordinary share, the company announced.The offer price...
